EBITDA for Q2 FY22 has been posted at Rs 650 million
HealthCare Global Enterprises (HCG) announced its financial results for the quarter (Q2) and six months ended September 30, 2021. The consolidated income from operations (Revenue) was Rs 3,520 million as compared to Rs 2,479 million in the corresponding quarter of the previous year, reflecting year-on-year growth of 42 per cent.
The consolidated Profit Before Depreciation and Amortization, Finance Costs, Exceptional Items and Taxes (EBITDA) was Rs 650 million, as compared to Rs 340 million in the corresponding quarter of the previous year, a growth of 91.1 per cent year-on-year and 19 per cent quarter-on-quarter.
Consolidated Profit Before Other Income, Depreciation and Amortization, Finance Costs, Exceptional Items and Taxes (Operating EBITDA), was Rs 617 million, as compared to Rs 300 million in the corresponding quarter of the previous year, a growth of 105.7 per cent year-on-year and 20.5 per cent quarter-on-quarter.
Operating EBITDA for Existing centres was Rs 598 million, a growth of 81.7 per cent year-on-year and 12.4 per cent quarter-on-quarter, reflecting an Operating EBITDA margin of 21.9 per cent.
Operating EBITDA from new centres was Rs 19 million, as compared to the loss of Rs 29 million in the corresponding quarter of the previous year and loss of Rs 19 million in the previous quarter. The consolidated profit after Taxes and Minority Interest (PAT) was a profit of Rs 1,031 million, as compared to a loss of Rs 223 million in the corresponding quarter of the previous year.
In Q2FY22, the company registered a strong revenue growth of 57.9 per cent y-o-y and 10.1 per cent q-o-q. The recorded positive EBITDA with several centres witnessing a turnaround in EBITDA (unit level). Several regions delivered double-digit revenue growth on a sequential basis on the back of gradual unlocking of the economy. Maharashtra upsurge continued across all centres and delivered 17.5 per cent revenue growth q-o-q. East India witnessed a continuance in its growth path with 20.1 per cent revenue growth q-o-q. North India recorded high growth of 42.1 per cent q-o-q.
Dr BS Ajaikumar, Executive Chairman, HealthCare Global Enterprises said, “The company has turned in industry-leading revenue growth this quarter, which is also backed by improving profitability, especially among the new centres that have not yet reached the mature stage of operations. The growth opportunities ahead of us in the domestic business is quite strong and we are also seeing a turnaround in the number of international patients visiting our centres with the easing of travel restrictions. Milaan, our fertility centre has also performed very well with a growth of 57 per cent on the back of a new leadership team under Shailesh Guntu aided by our focus on digital outreach which is delivering us the desired results.”
